Holiday Sale | Save 50%
Holiday Sale | Save 50%
Published

DCB is an effective option for PCI in patients with diabetes - Cardiovascular News

Summary by Cardiovascular News
Diabetes is one of the strongest risk factors for coronary disease, Pedro Lemos (Hospital Israelita Albert Einstein, São Paulo, Brazil) tells Cardiovascular News, discussing his strategies for managing the treatment of diabetic patients in the cath lab. In this interview, he explains why using a drug-coated balloon (DCB) may be an appealing option when it comes to the treatment of coronary artery disease, particularly among a subset of patients …
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)